Chief Executive Officer
Iain was appointed to the Cancer Research UK board in August 2009. He oversees Cancer Research UK's portfolio of research across discovery science, translational research, clinical and population research. This research portfolio includes the international Cancer Grand Challenges programme, a large clinical trial portfolio and oversight of Cancer Research UK's institutes and centres.
As CEO of Cancer Research Horizons, he is also responsible for ensuring research outputs are developed and commercialised, often in partnership with biotech and pharmaceutical companies to ensure rapid and effective patient impact.
Iain is a member of several boards including the Francis Crick Institute, the CRUK Scotland Institute, American Friends of Cancer Research, and is a Non-Executive Director at the British Medical Journal.